News
« Previous EntriesNext Entries »Midrin Equivalent Now Available at Pharmacies
Monday, December 5th, 2011An equivalent to Midrin, which is made of the exact same ingredients as Midrin was, is now readily available. My pharmacist called to tell me the news and I had the pleasure of letting my headache specialist know. Teri Robert of Migraine.com found that Macoven Pharmaceuticals makes the Midrin equivalent currently available. If your pharmacist doesn’t [...]
Michele Bachmann: Raising the Question of The Impact of Migraine
Friday, July 22nd, 2011You likely know by now that presidential hopeful Michele Bachmann has migraine. Whether her migraine episodes could impede her ability to run the country is one of the major questions now posed by news media. Let me repeat: Migraine, long dismissed as “just a headache,” is being treated as a serious threat to someone’s ability [...]
New Migraine Drug Telcagepant on Hold, Perhaps Permanently
Friday, April 24th, 2009Telcagepant, a migraine abortive with much success in clinical trials, is now on hold. It will not be submitted to the FDA for approval this year, as Merck previously announced. Originally studied for intermittent use, patients in an early trial to see if the drug could be used as a daily preventive developed high levels [...]
FDA Approves Generic Version of Migraine Preventive Drug Topamax (Topiramate)
Friday, April 3rd, 2009The FDA has approved production of topiramate, the generic version of migraine preventive drug Topamax. It will be available in multiple strengths from 17 different manufacturers. This is great news for the many people who have found relief from migraines or headaches with Topamax. Except for the side effects, which many find intolerable, Topamax is [...]
Crossing Allergies Off the Migraine Trigger List & Adding Nasal Irrigation as a New Treatment
Monday, March 23rd, 2009Of the 33 allergens tested for in a basic allergy panel, I’m allergic to nothing. I’m happy with the results, even though it means crossing yet another possibility off the list. I used to get discouraged when I hit a dead end. I’m not now; just glad to not have to deal with allergy shots. [...]
Headache & Migraine News Updates on The Daily Headache
Tuesday, March 17th, 2009I’m forever reading news I want to share with you, then don’t have the energy to write a post. News & Notes, now in the right sidebar, highlights important stories in the news and on blogs. Follow any of the links and you’ll see my comments on the story. I’ll still write in-depth posts sometimes, [...]
Generic Imitrex (Sumatriptan) Tablets & Injections Available in US
Friday, January 30th, 2009Tablet and injection versions of generic Imitrex (sumatriptan) are available in the US. Doses are 25mg, 50 mg, and 100mg tablets and 4mg and 6mg injections (kits or pre-filled syringes). Patients have reported prices between $35 and $200! Imitrex’s patent doesn’t actually expire until February; a reader suggested it might be less expensive then. The [...]
Migraine Linked to Depression, Anxiety and Other Mental Disorders
Friday, January 23rd, 2009People with migraine are likely to have mood disorders, like major depression, anxiety and panic attacks. This is according to a new study, which supports findings of previous studies that have also shown the coexistence, or comorbidity, of migraine and these disorders. From the current study’s press release (emphasis mine): Mood Disorders, Migraines Might Be [...]
Vote for The Daily Headache
Thursday, January 22nd, 2009Vote now for The Daily Headache in the Wellsphere Health Blogger Awards. It’s a late entry, so please vote now and spread the word! The deadline in January 31. Thanks! for The Daily Headache thedailyheadache.com
Lower Risk of Breast Cancer for Women With Migraine
Thursday, November 6th, 2008Finally, some good news for migraineurs. Women with migraine had a 30 percent lower risk of breast cancer than those without, according to a recently released study. Hormonal changes, which commonly trigger migraine, are a potential link. In particular, migraine history appeared to reduce the risk of the most common subtypes of breast cancer: those [...]
« Previous EntriesNext Entries »
